Legal & General Group PLC Immunity Bio, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 142,061 shares of IBRX stock, worth $558,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares

142,061

Previous 115,146 23.37%

Holding current value

$558,299

Previous $618,000 45.15%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $129,730 - $246,272	26,915 Added 23.37%	142,061 $897,000
Q1 2024 May 14, 2024	SELL	$3.23 - $6.17 $17,387 - $33,213	-5,383 Reduced 4.47%	115,146 $618,000
Q4 2023 Feb 15, 2024	BUY	$1.25 - $5.21 $3,207 - $13,368	2,566 Added 2.18%	120,529 $605,000
Q3 2023 Nov 14, 2023	SELL	$1.29 - $3.1 $1,809 - $4,349	-1,403 Reduced 1.18%	117,963 $199,000
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $97,673 - $409,207	63,839 Added 114.97%	119,366 $331,000
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $14,416 - $51,045	10,679 Added 23.81%	55,527 $101,000
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $4,893 - $7,616	-1,125 Reduced 2.45%	44,848 $227,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $14,366 - $25,308	3,936 Added 9.36%	45,973 $229,000
Q2 2022 Aug 22, 2022	BUY	$2.68 - $6.14 $26,526 - $60,773	9,898 Added 30.8%	42,037 $157,000
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $5,873 - $8,757	1,163 Added 3.75%	32,139 $180,000
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $170,149 - $264,223	18,555 Added 149.38%	30,976 $301,000
Q2 2021 Aug 12, 2021	BUY	$13.41 - $22.4 $40,203 - $67,155	2,998 Added 31.82%	12,421 $178,000
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $120,897 - $398,121	9,423 New	9,423 $224,000

Others Institutions Holding IBRX

# of Institutions

216

Shares Held

63.3M

Call Options Held

1.43M

Put Options Held

4.12M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.57B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Immunity Bio, Inc. Transaction History